Gate Square “Creator Certification Incentive Program” — Recruiting Outstanding Creators!
Join now, share quality content, and compete for over $10,000 in monthly rewards.
How to Apply:
1️⃣ Open the App → Tap [Square] at the bottom → Click your [avatar] in the top right.
2️⃣ Tap [Get Certified], submit your application, and wait for approval.
Apply Now: https://www.gate.com/questionnaire/7159
Token rewards, exclusive Gate merch, and traffic exposure await you!
Details: https://www.gate.com/announcements/article/47889
Major Shareholder Proposes Delisting: Venus Concept Stock Surges 405% on Strategic Shift
Venus Concept Inc. (VERO), a leading player in the medical aesthetics technology sector, witnessed a dramatic stock surge during Friday’s pre-market session. The company’s shares climbed 405%, reaching $7.25, following the disclosure of significant strategic developments outlined in an amended 13D/A filing submitted on January 15, 2026.
The filing reveals that Madryn Asset Management has accumulated a dominant 91% stake in Venus Concept, controlling 18,763,125 shares. This substantial holding positions the asset management firm as the company’s principal stakeholder with significant influence over corporate decisions.
Strategic Shift and Operational Restructuring
According to the amended filing, Madryn Asset Management communicated with Venus Concept’s board of directors on January 13, 2026, expressing its intention to pursue operational efficiency measures. Most notably, the major shareholder outlined a preference for the company to explore “the potential delisting and deregistration of the company’s Common Stock,” signaling a possible transition away from public market operations.
Company Background and Market Position
Venus Concept operates as a global innovator in medical aesthetics technology, with a specialized focus on energy-based devices (EBDs) and robotic hair-restoration systems. The company’s technology portfolio encompasses body contouring solutions, skin tightening treatments, facial rejuvenation services, resurfacing procedures, and hair-removal systems. These products have achieved market presence across more than 60 countries worldwide.
Trading History and Current Performance
Over the past 12 months, VERO has fluctuated within a range of $1.39 to $14.50, reflecting the volatility typical of smaller-cap healthcare technology stocks. The 405% pre-market surge represents a substantial movement, potentially reflecting investor reaction to the disclosed strategic initiatives and the significant influence held by Madryn Asset Management over the company’s future direction.